Outcome of routine testing for HCV and HBV in patients attending and admitted in various surgical units of a tertiary care institute
Abstract
Background: Hepatitis B and C virus remain leading causes of morbidity and mortality. Unfortunately, once inflicted, these infections show poor response to the available treatment modalities. So the focus remains on preventive strategies, to avoid spread of infection. There is lack of routine serological screening prior to surgery which is one of the factors responsible for increased disease transmission.
Material and Methods: The present study involved retrospective analysis of 9272 routine blood samples from all ages and both sexes who were attending and admitted in different surgical departments. These patients were screened by rapid immunochromatographic assay for qualitative detection of anti- HCV antibodies and HBsAg to know their carrier status prior to any surgical intervention.
Results: Out of 9272 samples tested, 155 (3.6%) tested positive for anti- HCV antibodies and 162 (3.26%) for HBsAg. Seroprevalence of HCV was 3.77 %( 96) and 3.36% (59) in male and female respectively, with preponderance among age group of 41-60 (43.87%) and 21- 40 years (39.35%). HBsAg detection revealed seropositivity of 3.89 %( 93) in males; 2.67 %( 69) in females, with predominance in young adults of 21-40 (43.83%) followed by 41-60 (24.07%) years. Maximum number of seropositive cases for both HCV and HBV were from General surgery department as 63.23% & 53.09% respectively.
Conclusion: The study estimated high prevalence of HBV and HCV on routine screening of patients reporting to various surgical departments. Healthcare providers have significantly high risk of infectivity along with further transmission of the disease if pre-operative screening and standard precautions are not followed strictly.
Downloads
References
2. Behal R, Jain R, Behal KK, Bhagoliwal A, Aggarwal N, Dhole TN. Seroprevalence and risk factors for hepatitis B virus infection among general population in Northern India. Arq. Gastroenterol 2008 ;45(2):137-40. [PubMed]
3. Kurien T, Thyagarajan SP, Jeyaseelan L, Peedicayil A, Rajendran P, Sivaram S, Hansdak SG, Renu G, Krishnamurthy P, Sudhakar K, Varghese JC; STD Study Group. Community prevalence of hepatitis B infection and modes of transmission in Tamil Nadu, India. Indian J Med Res 2005 ;121(5):670-5.[ PMID:15937371]
4. Russmann S, EA Dowlatshahi, G Printzen, S, Habicht, J Reichen and H Zimmermann. Prevalence and associated factors of viral hepatitis and transferrin elevations in 5036 patients admitted to the emergency room of Swiss University hospital: Cross-sectional study. BMC Gastroenterol 2007; 7(5). [DOI: 10.1186/1471-230X-7-5] [PubMed]
5. Trinks J, Gadano A and Argibay P. Evolving Trends in the Hepatitis C Molecular Epidemiology Studies: From the Viral Sequences to the Human Genome. Epidemiology Research International 2012; 1-10.[ doi.org/10.1155/2012/856810]
6. Shepard CW, Finelli L, Alter MJ . Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5(9):558-67.[ DOI: 10.1016/S1473-3099(05)70216-4]
7. Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol. J 2007; 4:104. [ doi: 10.1186/1743-422X-4-104] [PubMed]
8. Okonko IO , Okerentugba PO , Akinpelu AO. Prevalence of HBsAG among Attendees of ARFH Centre in Ibadan, Southwestern Nigeria. American-Eurasian Journal of Scientific Research 2012; 7 (3): 100-105. [PubMed]
9. Bhatta CP, Thapa B, Rana BB. Seroprevalence of hepatitis "B" in Kathmandu Medical College Teaching Hospital (KMCTH). Kathmandu Univ Med J 2003 ;1(2):113-6. [PMID: 16388209] [PubMed]
10. Sayed A Quadri, HJ Dadapeer, K Mohammed Arifulla, Nazia Khan. Prevalence of Hepatitis B Surface Antigen in hospital based population in Bijapur, Karnataka. Al Ameen J Med Sci 2013; 6(2):180-82. [PubMed]
11. Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol 2012 ;4(3):74-80 [doi: 10.4254/wjh.v4.i3.74]. [PubMed]
12. Sule WF, Okonko IO, Yunusa IP, Odu NN, Frank-Peterside N. Hepatitis B surface antigenemia (HBsAg) and risk factors of transmission among patients attending Universal Hospital, Ankpa, Kogi State, Nigeria. Nature and Science 2011;9(10):37-44. [PubMed]
13. Dutta S, Shivananda PG, Chatterjee A. Prevalence of hepatitis B surface antigen and antibody among hospital admitted patients in Manipal.Indian J Public Health 1994; 38(3):108-12. [PMID: 7774971] [PubMed]
14. Sood S, Malvankar S. Seroprevalence of Hepatitis B surface antigen, antibodies to the Hepatitis C virus, and human immunodeficiency virus in a hospital-based population in Jaipur, Rajasthan. Indian J Community Med 2010; 35:165-9 [DOI: 10.4103/0970-0218.62588]
15.Cariappa MP, Jayaram J, Bhalwar R, Praharaj AK, Mehta VK, Kapur LK. Epidemiological differentials of Hepatitis B carrier state in the army: A community based seroepidemiological study. Med J Armed Forces India 2004;60:251-4.[ DOI: http://dx.doi.org/10.1016/S0377-1237(04)80057-1] [PubMed]
16. Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, Zeynep S. Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas. Jpn J Infect Dis 2005 ;58(1):15-9. [PMID: 15728984] [PubMed]
17. Lawal OA, Bakarey AS, Uche LN, Udeze AO, Okonko IO. HBV Infection among Intending Blood Donors Who Incidentally Tested Positive to HIV Antibody in Two Blood Banks in Ibadan, Nigeria. World Applied Sciences J 2009 ; 7(10): 1269-74.
18. Easow JM, Shankar PR, Tuladhar R, Singh YI. Seroepidemiology of Hepatitis B virus infection diagnosed at a teaching hospital in Western Nepal: A prospective study. J Clin Diagn Res 2010; 4:3100-3105.
19. Chander A, Pahwa VK. Status of infectious disease markers among blood donors in a teaching hospital, Bhairahawa, western Nepal. J Commun Dis. 2003 ;35(3):188-97. [ PMID:15796411]
20. Kaur R, Gur R, Berry N, Kar P. Etiology of endemic viral hepatitis in urban North India. Asian J Trop Med Public Health 2002; 33(4):845-8.[ PMID:12757236] [PubMed]
21. Berry V, Lal M, Rantai S, Singh N. ‘Prevalence of Hepatitis C in North India’ A three years study. JARBS 2012; 4(2): 120-22.
22. Rajani M, Jais M. Age-wise seroprevalence of hepatitis C virus infection in clinically suspected infectious hepatitis patients attending a tertiary care hospital in Delhi. Int J Med Public Health 2014;4:78-81.[ DOI: 10.4103/2230-8598.127163]
23. Mukhopadhya A . Hepatitis C in India. J. Biosci. 2008; 33 (4); 465–73. [DOI 10.1007/s12038-008-0065-0] [ PMID:19208972]
24. Verma R, Behera BK, Jain RB, Arora V, Chayal V, Gill PS. Hepatitis C, a silent threat to the community of Haryana, India: a community-based study. Australas Med J 2014 Jan 31;7(1):11-6.[ doi: 10.4066/AMJ.2014.1883] [PubMed]
25. Siddiqui FA, Akhtar K, Sherwani RK, Rehman K, Alam F, Ansari A. Prevalence of hepatitis C virus in Aligarh: a seven year experience. Indian J Community Med 2009 Jul;34(3):264-5. [doi: 10.4103/0970-0218.55299]
OAI - Open Archives Initiative
